acegame 888 withdrawal
2025-01-09
acegame 888 withdrawal
Tech Stocks Surge Amid Fed Rate Cut Hopes
The Los Angeles Lakers are riding a slippery slope amid their recent struggles. The last eight games have not been too polite to the Los Angeles Lakers. They started the new season strong, which came with the arrival of first-year head coach JJ Redick. They’ve l ost six of their last eight games . Some are calling the fall of LeBron James 22 years into his career, as he’s been consistent for two-plus decades. Others are blaming Redick. Evidently, it’s hard to place the blame anywhere but the management. They put the players on the court that the coaching staff has to work with. Also, the players determine their effort levels to execute the coaching staff’s game plan . Anthony Davis had a recent issue as the Lakers lost their second straight game. Chandler Parsons, a former NBA player, offered a brutal assessment of the situation on “Run It Back.” Anthony Davis wasn’t trying in the Lakers’ recent loss, Parsons claims The Lakers’ last two losses have come by a total margin of 70 games. That’s a sign of a terrible basketball team, especially as they have lost six of their last eight games. They are in poor form and it’s not something Redick can directly fix. In the club’s loss to the Heat, Parsons noticed that Davis wasn’t even trying. The superstar who is having an MVP-caliber player left no effort out on the floor. He had no energy. It wasn’t just Davis, though. It was the entire five on the floor. “Look at Anthony Davis right now,” Parsons said of a video of his effort. “That’s a Defensive Player of the Year, a defensive talent playing right there, and that’s the effort I’m getting? I literally found myself googling what club was open on a Tuesday night in Miami where the Lakers went. That’s the only thing I can think of.” He added: “This was an embarrassing pathetic performance. This was just effort, this was will, this was nothing to do with basketball. “Anthony Davis it looked like he did not care, that’s the most concerning part, I know it’s one game, but this is one you look back on, this is detrimental to the game, this is embarrassing for the league, it’s that bad.” Davis is the anchor of the defense. Sure, the guards might not have had energy defensively, nor anyone else on the floor. But Davis can spark energy with a few hustle plays and communication from where he’s at on the floor. Someone has got to set the tone on the floor for the Lakers. Redick can’t do it from the sideline and Rob Pelinka can’t make a trade mid-game to swap out players. Lakers legend Magic Johnson is “embarrassed” for the team There are not many words to describe what the Lakers are right now, but Magic Johnson — a Lakers legend — put it perfectly. He was “embarrassed” after their abysmal performance in Miami. “I’m embarrassed for the Lakers. They were down 32 points to the Miami Heat 105-72 at the end of the third quarter,” Johnson shared online. I’m embarrassed for the Lakers. They were down 32 points to the Miami Heat 105-72 at the end of the third quarter. This is a fair reaction for even players and fans who didn’t represent the franchise and aren’t legends within the building. They are the Lakers — one of the most powerful sports organizations in the world. The amount of problems within the franchise goes beyond one coach or player. They’ve got a management issue. They’ve got a talent issue. They don’t have the correct resources to be a contending NBA team. For Johnson, and others, it’s glaringly evident that the Lakers don’t have what it takes to win games right now, and “embarrassed” is a great way to put it. This article first appeared on NBA Analysis Network and was syndicated with permission.
Pep Guardiola has stressed Manchester City’s current malaise is not down to one player as he again defended Erling Haaland. City’s 2-1 loss at Aston Villa on Saturday, the Premier League champions’ ninth defeat in 12 matches in all competitions, saw Haaland fail to score for the fifth time in six outings. Advertisement After the game the Norway striker told TNT Sports: “First I’m looking at myself. I haven’t been scoring my chances. I have to do better, I haven’t been good enough.” Advertisement City boss Guardiola subsequently stuck up for Haaland, who has netted 108 times for the club since joining in 2022, saying that “without him we will be even worse” and that “he needs to be delivered the right balls in the right spots”. And speaking on Christmas Eve at his press conference ahead of the Boxing Day home clash with Everton, Guardiola said: “It’s about us, not just one player. “When in the past we score goals and Erling was so prolific, helping us, it was because of the team. “And when you have problems at the back, in the middle, it is for everyone, it is a team, it is not about one player. It would be easy, if it was just one player, the reason why. It’s not about that. Advertisement PEP 💬 It is about us, not just one player... when you have problems at the back and middle, it is all about the team, not just one player... Erling [Haaland] is so important for us, will be important for us and has been and we need to use him better. pic.twitter.com/VBgJywyCT2 — Manchester City (@ManCity) December 24, 2024 Advertisement “Erling is so important for us, will be so important for us, has been. (We have to) try to do things better, to use him better.” He added: “In this situation, this tendency for all of us (is to say) ‘the reason why is this one, and this one and this one’. It’s about us, about everyone. “The guys are running, making effort more than ever. All the tendency ‘it’s because we don’t run, because we don’t fight, the reason why is this situation or this player or this manager’... It’s not about that. Advertisement “It’s many little details or big details that make all together not as good as we were. But we have another opportunity on Boxing Day.” City have a sidelined list that includes key midfielder Rodri, recovering from an anterior cruciate ligament injury suffered in September, and Ruben Dias, who was ruled out for up to four weeks after sustaining a muscular problem in the 2-1 loss to Manchester United on December 15. Fellow defender John Stones made his return to action in the Villa game after a foot issue, only to be substituted at half-time. City have been assessing him, along with goalkeeper Ederson and midfielder Matheus Nunes, both of whom were absent on Saturday. What is an unprecedented slump in results in Guardiola’s managerial career has featured six losses in eight in the league. And City, who had gone into the season targeting a fifth successive title under the 53-year-old, head into Christmas lying seventh in the table, 12 points adrift of leaders Liverpool having played a game more. Their next five league fixtures are all against sides currently in the bottom half, with Everton sat 15th. Guardiola emphasised the Toffees should not be regarded as the “perfect opponent”, and added: “It’s about us, to come back at our best. We will take time because we don’t have players, but we have to get results as quick as possible.” Ahead of the 12.30pm kick-off, City’s players are set to train on Christmas Day before staying at the training ground that night, and Guardiola said: “Today they will be at home with the families, tomorrow (they will be) in the morning and in the night they will be here – hopefully they want to be here, because it’s our job and our duty.”Hegseth meets with moderate Sen. Collins as he lobbies for key votes in the Senate
Mutual of America Capital Management LLC Has $2.57 Million Holdings in Grid Dynamics Holdings, Inc. (NASDAQ:GDYN)Tesla Is Analyst's Top 2025 Stock Pick: Elon Musk Political Involvement May 'Accelerate' EV Maker Beyond Autos
Offering patients an injection is more effective than the current care of steroid tablets and cuts the need for further treatment by 30%, according to a study. Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used as a repeat treatment for severe asthma at a low dose, but a new clinical trial has found that a higher single dose can be very effective if injected at the time of a flare-up. The findings, published in the Lancet Respiratory Medicine, included 158 people who needed medical attention in A&E for their asthma or COPD attack (COPD is a group of lung conditions that cause breathing difficulties). Patients were given a quick blood test to see what type of attack they were having, with those suffering an “eosinophilic exacerbation” involving eosinophils (a type of white blood cell) being suitable for treatment. Around 50% of asthma attacks are eosinophilic exacerbations, as are 30% of COPD ones, according to the scientists. The clinical trial, led by King’s College London and carried out at Oxford University Hospitals NHS Foundation Trust and Guy’s and St Thomas’ NHS Foundation Trust, saw patients randomly split into three groups. One group received the benralizumab injection and dummy tablets, another received standard care (prednisolone steroids 30mg daily for five days) and a dummy injection, and the third group received both the benralizumab injection and steroids. After 28 days, respiratory symptoms of cough, wheeze, breathlessness and sputum were found to be better in people on benralizumab. And after 90 days, there were four times fewer people in the benralizumab group who failed treatment compared with those receiving steroids. Treatment with the benralizumab injection also took longer to fail, meaning fewer visits to a GP or hospital for patients, researchers said. Furthermore, people also reported a better quality of life on the new regime. Scientists at King’s said steroids can have severe side-effects such as increasing the risk of diabetes and osteoporosis, meaning switching to benralizumab could provide huge benefits. Lead investigator Professor Mona Bafadhel, from King’s, said: “This could be a game-changer for people with asthma and COPD. “Treatment for asthma and COPD exacerbations have not changed in 50 years, despite causing 3.8 million deaths worldwide a year combined. “Benralizumab is a safe and effective drug already used to manage severe asthma. “We’ve used the drug in a different way – at the point of an exacerbation – to show that it’s more effective than steroid tablets, which is the only treatment currently available.” Researchers said benralizumab could also potentially be administered safely at home or in a GP practice, as well as in A&E. First author Dr Sanjay Ramakrishnan, clinical senior lecturer at the University of Western Australia, said: “Our study shows massive promise for asthma and COPD treatment. “COPD is the third leading cause of death worldwide but treatment for the condition is stuck in the 20th century. “We need to provide these patients with life-saving options before their time runs out.” Dr Samantha Walker, director of research and innovation at Asthma and Lung UK, welcomed the findings but said: “It’s appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years, indicating how desperately underfunded lung health research is.” AstraZeneca provided the drug for the study and funded the research, but had no input into trial design, delivery, analysis or interpretation.Manchester United criticised over ‘offensive’ price increase for match ticketsAP Business SummaryBrief at 1:39 p.m. EST
A team of researchers from the U.S. Department of Energy Ames National Laboratory developed a magnetocaloric heat pump that matches current vapor-compression heat pumps for weight, cost, and performance. Current heating and cooling devices are based on vapor-compression technology, which is over 100 years old. They rely on refrigerants that contribute to , and when they leak the chemicals are harmful to people and the environment. Magnetocaloric heat pumps are a promising replacement for cooling and heating. They can eliminate refrigerant emissions and require less energy to operate. Until now, magnetocaloric devices have not matched vapor-compressors in all three aspects of weight, cost, and performance. Julie Slaughter, the research team leader, explained that their investigation began by building a magnetocaloric heat pump. "We first looked at what is out there, and how close the existing magnetocaloric devices are to matching compressors," she said. "Next we developed a baseline design and then asked, "Okay, now how far can we push the technology?'" The work is in the journal . A magnetocaloric heat pump works by changing the magnetic field applied to a magnetocaloric material while pumping fluid to move heat. Slaughter explained that this is typically done with permanent magnets. The core of the involves spinning permanent magnets relative to the magnetocaloric material and using magnetic steel to keep the magnetic field contained. The arrangement of these three pieces plays a major role in the team's predictions as they examined how to make the more power dense. Another part of their investigation involved evaluating the two most common magnetocaloric materials used in these heat pumps. Gadolinium and lanthanum-iron-silicon-hydride-based material. "In our baseline device, we kept it simple by using a single material, gadolinium. Lanthanum-iron-silicon materials have a higher power capability than gadolinium. So, that naturally increases the . They're just not as readily available and require multiple materials in one device to get good performance," said Slaughter. "In our evaluations, we included estimates of LaFeSi performance for the most power-dense devices." Slaughter's team focused on using space and materials more efficiently, and reducing the amount of permanent magnet material and magnetic steel needed for the pump to operate efficiently. These efforts helped to make the core system pieces match the weight of compressors available today. "We were able to show that we are competitive with the power density of some of the compressors that are out there today," said Slaughter. "The and the magnetic steel make up most of the mass rather than the expensive magnetocaloric material, and that's really helpful for affordability. We assumed, if a device weighs about the same, the cost will be about the same in mass production."
Related hot word search:
Previous: acegame 888 casino login
Next: acegame888 apk